<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368811">
  <stage>Registered</stage>
  <submitdate>30/06/2015</submitdate>
  <approvaldate>10/07/2015</approvaldate>
  <actrnumber>ACTRN12615000719538</actrnumber>
  <trial_identification>
    <studytitle>Does injection of local anaesthetic into the joint after total knee replacement affect range of motion?</studytitle>
    <scientifictitle>Does instillation of periarticular local anaesthetic after total knee replacement affect range of motion: A Randomized Control Trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition> Knee range of motion following total knee replacement</healthcondition>
    <healthcondition>Osteoarthritis</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Our intervention will be the surgeons standard practice of 200mg of naropin (ropivacaine) and 0.5mg of adrenaline, used as local infiltration analgesia injected around the joint replacement in TKA. </interventions>
    <comparator>The control knee which will be the knee (left or right) injected with 100ml of normal saline. </comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The primary outcome is to determine whether local infiltration analgesia in bilateral TKA leads to a reduction in range of knee flexion in bilateral TKA. 

</outcome>
      <timepoint>Range of knee flexion will be measured using a goniometer at baseline (pre-operation) and at 6 weeks post operation.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To determine whether local infiltration analgesia increases manipulation under anaesthesia (MUA) rates</outcome>
      <timepoint>At 6 weeks post operation, knee flexion is measured using a goniometer. If knee flexion is reduced below 90 degrees, patients undergo MUA to increase the knee ROM and flexion usually 8-10 weeks post operation.

We will use a chi square test in order to determine whether there is a significant difference between incidence of manipulation under anaesthesia rates between the groups.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>To determine whether periarticular local analgesia improves post operative pain in the first 48 hours. </outcome>
      <timepoint>A 100mm visual analogue scale (VAS) will be used to asse pain scores at 8, 24 and 48 hours after surgery.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All patients with a diagnosis of osteoarthritis undergoing bilateral total knee arthoplasty</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients with allergies to any of the used analgesic agents, patients unable to undergo a femoral sheath or sciatic nerve block. Patients with prior surgeries on their knee, for example prior knee arthroscopies, high tibial osteotomy, tibial or femoral nail, open reduction and internal fixation of the distal femur will all be excluded from the study. Patients with either a varus or valgus knee deformity were excluded from the study. </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>20/07/2015</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>26</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Michael Hunter</primarysponsorname>
    <primarysponsoraddress>Gosford Hospital, Holden Road, Gosford, NSW 2250</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to investigate whether our standard practice of injecting local anaesthetic into the knee joint for total knee replacements impacts knee range of motion at 6 weeks post operation for total knee replacement.

We hypothesize that local infiltration analgesia during operation in total knee replacements negatively impacts the knee range of motion.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>NSLHD HREC</ethicname>
      <ethicaddress />
      <ethicapprovaldate>25/02/2015</ethicapprovaldate>
      <hrec>HREC/14/HAWKE/418</hrec>
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Michael Hunter</name>
      <address>Gosford Hospital, Holden street, Gosford, NSW 2250</address>
      <phone>+61 2 43202111</phone>
      <fax />
      <email>claudetteandmichael@hotmail.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Antony Nguyen</name>
      <address>Concord Hospital, Hospital Road, Concord, NSW 2139</address>
      <phone>+61 2 97675000</phone>
      <fax />
      <email>antony_nguyen@hotmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Antony Nguyen</name>
      <address>Concord Hospital, Hospital Road, Concord, NSW 2139</address>
      <phone>+61 2 97675000</phone>
      <fax />
      <email>antony_nguyen@hotmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>